MENU
ACAD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ACADIA Pharmaceuticals (ACAD) Ownership - Who owns ACADIA Pharmaceuticals?
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
12830 El Camino Real
Phone
+1 858 558-2871
Employees
598
Web
https://www.acadia.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.47B
P/E Ratio
10.90
Total Cash
755.99M
Projected Growth
N/A
Total Debt
52M
Revenue
957.8M
Risk (Beta)
0.80
Dividend Yield
N/A
Total Cash/Share
4.53
Total Debt/Equity
N/A
Revenue/Share
5.76 USD as % of share price
Fundamentals
ACAD
Capitalization
2.47B
P/E Ratio
10.90
Risk (Beta)
0.80
Dividend Yield
N/A
Total Cash
756M
Total Cash/Share
4.53
Total Debt
52M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.76%
Revenue
958M
ROE
N/A
Book Value
733M
P/B Ratio
3.37
Cash Flow
N/A
Earnings
1.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
16K
Current Ratio
2.38
Current Revenue Per Employee
396944.97
Dividends Per Share - Security
N/A
EBITDA
100M
Float
N/A
Float - Current
N/A
Gross Income Margin
91.60
Revenue To Assets
23.39
Shares Held By Institutions
5.42B
Shares Outstanding - Current
167M
Total Liabilities
455M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-20.327
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceuticals drugs for treatment of central nervous system disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
12830 El Camino Real
Phone
+1 858 558-2871
Employees
598
Web
https://www.acadia.com